Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| classical monocyte | 5 studies | 25% ± 7% | |
| non-classical monocyte | 3 studies | 35% ± 8% | |
| macrophage | 3 studies | 19% ± 3% | |
| dendritic cell | 3 studies | 38% ± 10% | |
| natural killer cell | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of TOR2A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 754.08 | 180 / 180 | 100% | 16.83 | 430 / 430 |
| pancreas | 100% | 608.35 | 328 / 328 | 100% | 12.11 | 178 / 178 |
| uterus | 100% | 710.88 | 170 / 170 | 100% | 17.28 | 459 / 459 |
| esophagus | 100% | 680.32 | 1444 / 1445 | 100% | 16.45 | 183 / 183 |
| liver | 100% | 607.21 | 226 / 226 | 100% | 9.99 | 405 / 406 |
| intestine | 100% | 887.37 | 964 / 966 | 100% | 20.59 | 525 / 527 |
| brain | 99% | 745.33 | 2625 / 2642 | 100% | 13.15 | 705 / 705 |
| thymus | 100% | 927.14 | 653 / 653 | 99% | 11.85 | 601 / 605 |
| prostate | 100% | 806.22 | 245 / 245 | 99% | 17.89 | 498 / 502 |
| skin | 100% | 682.06 | 1809 / 1809 | 99% | 12.72 | 468 / 472 |
| stomach | 100% | 761.10 | 358 / 359 | 99% | 18.68 | 283 / 286 |
| adrenal gland | 100% | 880.47 | 258 / 258 | 98% | 12.65 | 226 / 230 |
| breast | 100% | 613.04 | 459 / 459 | 98% | 16.78 | 1098 / 1118 |
| lung | 100% | 829.85 | 576 / 578 | 98% | 14.06 | 1137 / 1155 |
| bladder | 100% | 616.05 | 21 / 21 | 98% | 16.12 | 494 / 504 |
| kidney | 100% | 780.97 | 89 / 89 | 98% | 8.26 | 882 / 901 |
| eye | 0% | 0 | 0 / 0 | 100% | 11.21 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 18.93 | 29 / 29 |
| spleen | 100% | 1876.96 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 15.36 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 10.98 | 1 / 1 |
| adipose | 100% | 587.16 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 1223.64 | 924 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 94% | 356.34 | 1254 / 1335 | 0% | 0 | 0 / 0 |
| heart | 91% | 278.26 | 786 / 861 | 0% | 0 | 0 / 0 |
| muscle | 70% | 162.79 | 561 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007165 | Biological process | signal transduction |
| GO_0051085 | Biological process | chaperone cofactor-dependent protein refolding |
| GO_0005635 | Cellular component | nuclear envelope |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005179 | Molecular function | hormone activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0016887 | Molecular function | ATP hydrolysis activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | TOR2A |
| Protein name | Prosalusin (Torsin family 2 member A) (Torsin-2A) [Cleaved into: Salusin-alpha; Salusin-beta] Torsin-2A (Torsin family 2 member A) (Torsin-related protein 1) |
| Synonyms | UNQ6408/PRO21181 PSEC0218 TORP1 HEMBA1005096 |
| Description | FUNCTION: Salusins -alpha and -beta may be endocrine and/or paracrine factors able to increase intracellular calcium concentrations and induce cell mitogenesis. Salusins may also be potent hypotensive peptides. . |
| Accessions | ENST00000373281.8 [Q5JU69-2] ENST00000463256.5 [Q5JU69-5] ENST00000463577.2 [Q5JU69-5] ENST00000373284.10 [Q5JU69-1] Q8N2E6 ENST00000493439.1 [Q5JU69-5] ENST00000336067.10 [Q8N2E6-1] Q5JU69 ENST00000496460.5 [Q5JU69-5] |
